- Advertisement -
Andrew ‘Twiggy’ Forrest’s private investment group Tattarang has today made a $5 million investment in clinical drug development company Emyria (ASX: EMD) to accelerate the group’s cannabinoid and MDMA research.
The investment, which will see 20 million shares issued to Tattarang, gives…

